Purpose of review The risks of cerebrovascular manifestations due to SARS-CoV-2 infection
are significantly increased within the first 6 months of the infection. Our work aims to give an …

Background and purpose The full spectrum of neurological sequelae in COVID‐19 is
beginning to emerge. SARS‐CoV‐2 has the potential to cause both direct and indirect brain …

During the SARS-CoV2 pandemic, several cases of Posterior Reversible Encephalopathy
Syndrome (PRES) and of Reversible Cerebral Vasoconstriction Syndrome (RCVS) in …

Background: Central nervous system (CNS) symptoms may occur in patients with acute
COVID-19. The role of CSF examination in these patients remains to be established …

Background Numerous case reports and case series have described brain Magnetic
Resonance Imaging (MRI) findings in Coronavirus disease 2019 (COVID-19) patients with …

The rise in Coronavirus disease 2019 (COVID-19) cases is revealing its unique neurological
manifestations. In light of the emerging evidence, a possible association with Posterior …

Posterior reversible encephalopathy syndrome (PRES) is a reversible clinico-radiological
entity characterized by acute neurological symptoms and white matter vasogenic edema that …

Objectives: Severe, acute, respiratory syndromecoronavirus-2 (SARS-CoV-2) infections can
be complicated by central nervous system (CNS) disease. One of the CNS disorders …

Posterior reversible encephalopathy syndrome (PRES) is a rare complication that the exact
pathophysiological mechanism of which is still unclear. PRES most often occurs in …

We set out to describe in detail the afferent neuro-ophthalmological complications that have
been reported in association with coronavirus disease 2019 (COVID-19) infection. We …